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Anti-oxidative function of follicular 
fluid HDL and outcomes of 
modified natural cycle-IVF
Ruxandra A. Nagy1,2, Aafke P. A. van Montfoort2,3, Henk Groen4, Irene Homminga2, 
Daniela Andrei1,2, Rima H. Mistry1, Josephine L. C. Anderson1, Annemieke Hoek2 & 
Uwe J. F. tietge1,5,6
High density lipoproteins (HDL) are the main cholesterol carriers in follicular fluid (FF), the natural 
environment of oocyte development. Additionally, HDL have critical biological functions such as 
anti-oxidative capacity, which have not been studied in reproduction. Therefore, this study aimed 
to investigate whether the anti-oxidative function of FF-HDL is associated with fertility outcomes. 
From 253 women undergoing modified natural cycle (MNC)- IVF at a single academic centre FF and 
plasma were collected (n = 375 cycles). Anti-oxidative function of FF was mainly attributable to 
HDL (n = 8; 83%). FF-HDL had a higher anti-oxidative function than plasma HDL (n = 19, P < 0.001) 
coinciding with increased vitamin E and sphingosine 1 phosphate content (P = 0.028 each). Proteomic 
analysis indicated no significant differences in major anti-oxidative proteins such as paraoxonase 1, 
apolipoprotein (apo) A-I or apoA-IV between FF-HDL and matched plasma-HDL (n = 5), while apoC-III, 
apoE and apoC-II were relatively lower in FF-HDL. Finally, FF-HDL anti-oxidative function was related 
to a decrease in the odds of the oocyte undergoing normal fertilization, an association that persisted 
after adjustment for confounders (odds ratio 0.97 (0.93–1), P = 0.041). In conclusion, FF-HDL has 
considerable anti-oxidative properties that might be relevant for embryo quality.
The role of high density lipoproteins (HDL) in health and disease is traditionally viewed in the context of protec-
tion against atherosclerotic cardiovascular disease (CVD). Although circulating HDL-cholesterol levels are con-
sistently inversely correlated with incident CVD events in large population studies, recent genetic research and 
disappointing pharmacological intervention studies resulted in a shift of concept towards HDL function being 
more important than HDL-cholesterol1. While the body of literature on HDL function in the cardiovascular field 
is increasing, this concept remains insufficiently explored in other fields where HDL might play a physiological 
role, such as reproduction2.
In female reproduction, follicular fluid (FF) is the natural environment for the final phase of oocyte mat-
uration. Its composition has been linked to oocyte growth and quality, and variations in the metabolic profile 
of FF, such as lipoproteins, certain bile acid species, glucose, lactate and other metabolites are associated with 
the developmental potential of embryos in in vitro fertilization (IVF) procedures3–5. A key component of FF is 
cholesterol, which is almost exclusively contained within HDL, which are believed to originate from the blood 
compartment3,6. During follicular maturation, HDL cholesterol homeostasis in FF is important as it provides 
the substrate for local steroid hormone production7. Additionally, HDL quantity and structure has been linked 
to oocyte quality in mice as exemplified by the presence of dysfunctional oocytes and subsequent infertility in 
female mice lacking the HDL receptor SR-BI8,9. In addition to cholesterol transport, HDL have a number of func-
tional properties. A key metric of HDL functionality is the ability to prevent oxidation10.
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Oxidative stress has a negative impact on reproductive fitness as exemplified in women with reproductive 
disorders such as polycystic ovarian syndrome and endometriosis11–14. Furthermore, unfavourable metabolic 
conditions including obesity, insulin resistance or other components of the metabolic syndrome are associated 
with decreased fertility on the one hand and with altered plasma HDL anti-oxidative function on the other10,15–19. 
However, despite the biological activities of HDL and their abundant presence in FF, the anti-oxidative prop-
erties of HDL in FF and their potential association with parameters of fertility have not been explored thus far. 
Therefore, the present study aimed to evaluate the relevance of anti-oxidative properties of FF-HDL for outcomes 
of modified natural cycle (MNC)-IVF. In contrast to classic hyperstimulation IVF, in MNC-IVF (a setting close 
to normal reproductive physiology) it is possible to associate each FF sample collected with one specific oocyte 
and subsequently one embryo.
Results
Study population characteristics. As detailed in methods, FF and plasma were collected between August 
2013 and April 2017 from a total of 620 MNC-IVF cycles derived from 253 patients (Fig. 1). Of these, 375 mon-
ofollicular MNC-IVF cycles corresponding to 215 patients were suitable for analysis. The vast majority of cycles 
were excluded because no oocyte was retrieved upon intended ovum pick-up or because there was visible blood 
contamination of FF. Out of the 375 cycles, 160 were obtained during the observational study period and 215 
during the prospective study. In total, there were 244 transferable embryos that resulted in 67 pregnancies. Table 1 
contains a description of HDL anti-oxidative capacity and patient characteristics at the time of ovum pick-up.
Anti-oxidative capacity of follicular fluid HDL. First, we determined how the anti-oxidative capacity 
of FF (containing virtually exclusively HDL as the sole lipoprotein subclass) compares to that of plasma HDL 
(obtained by precipitation of apoB-containing lipoproteins). For 19 randomly selected patients who fulfilled the 
above-mentioned selection criteria and underwent a first cycle MNC-IVF, the anti-oxidative capacity of FF and 
matching apoB-depleted plasma was measured. As shown in the supplementary table there were no major differ-
ences in patient characteristics between the selected subgroup and the whole study population. The percentage 
reduction in oxidation was consistently significantly higher in FF as compared to plasma HDL (84% [79.2–87.1] 
versus 67.2% [63.8–70.1]; p < 0.001; Supplementary Fig.). The correlation between the anti-oxidative function of 
FF and that of matching plasma did not reach significance (rs = 0.307, p = 0.201).
Next, we investigated the specific contribution of FF-HDL to the overall anti-oxidative properties of FF. For 
this purpose, eight patients were randomly selected who fulfilled the above-mentioned criteria and underwent a 
Figure 1. Flow diagram of sample selection. Of the 620 MNC-IVF cycles that were initially considered for 
inclusion in the study, 375 cycles were consistent with all of the selection criteria as detailed in methods. MNC, 
modified natural cycle.
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first cycle MNC-IVF. As indicated in the Supplementary Table, except for the lower proportion of patients who 
consumed alcohol, these patients did not differ in their clinical characteristics compared to the whole patient 
population. HDL was isolated from these FF samples by fast protein liquid chromatography (FPLC). Cholesterol 
measurements confirmed that almost all cholesterol in FF is contained within HDL particles3. Importantly, the 
anti-oxidative capacity of isolated FF-HDL accounted for 83% [77.2–90.4] of the total FF anti-oxidative capacity 
(whole FF 57.14% [55.15–58.89] versus FF-HDL 46.75% [45.35–50.75]).
In order to characterize the composition of FF-HDL in greater detail, proteomic analyses were carried out 
in matching plasma-HDL and FF-HDL (n = 6 patients) isolated by FPLC. FF-HDL and plasma-HDL from one 
patient with a high inflammatory load were subsequently excluded from the analysis. As summarized in Fig. 2 (for 
a complete list of proteins please see Supplementary Table 2) apolipoprotein C-III, apolipoprotein E and apolipo-
protein C-II were significantly enriched in plasma-HDL as compared to FF-HDL (each P < 0.05). For the other 
proteins, notably including proteins implicated in oxidative stress defence such as PON1, apoA-I or apoA-IV, 
no significant differences between FF-HDL and matched plasma-HDL were discernible. Next, we explored the 
content of anti-oxidative lipids in the different HDL preparations. Vitamin E and sphingosine-1-phosphate (S1P) 
were both present in FF-HDL at significantly higher levels than in matched plasma-HDL (vitamin E: FF-HDL 
4.21 [9.32–49.05] nmol/ml versus plasma-HDL 3.86 [2.50–27.41] nmol/ml, P = 0.028; S1P: FF-HDL 71.08 
[36.83–340.72] ng/l versus plasma-HDL 34.60 [25.02–224.99] ng/l, P = 0.028).
Intra-individual variation in the anti-oxidative function of follicular fluid HDL. The anti-oxidative 
function of FF-HDL was assessed in 215 patients (Fig. 1), and in 106 of them material from a minimum of 
two MNC-IVF cycles were available for comparison. For these, minimum and maximum values for FF-HDL 
anti-oxidant capacity were calculated and the difference was expressed as the intra-individual variance. There was 
a strong positive correlation between the minimum and maximum FF-HDL anti-oxidant function (minimum: 
78.7 [75.5–81.6], maximum 85.1 [81–88], rs = 0.508, p < 0.001, intra-individual variance 7.1 [3.3–11.4]), indicat-
ing that the anti-oxidative function of FF-HDL is a rather stable parameter.
Follicular fluid HDL anti-oxidative function in relation to embryo quality and pregnancy. We 
investigated the relation between FF-HDL anti-oxidative function and embryo quality as well as pregnancy 
occurrence (Table 2). Of the total 309 cycles during which an ICSI procedure was planned, in seven cycles the 
procedure was not carried out due to separation of the oocyte from the zona pellucida or abnormal oocyte mor-
phology. Of the remaining cycles, 16 oocytes were not injected due to insufficient spermatozoa. One oocyte was 
lost during removal of granulosa cells and after ICSI 15 oocytes degenerated. Of the total 366 oocytes (ICSI and 
IVF), in which development after fertilization was followed, 92 had an abnormal number of pronuclei or did not 
Total group P value
Reduction in oxidation (%) 81.7 ± 6.8 —
Age (years) 31.3 ± 3.4 0.474










   Duration of subfertility (months)b 35.6 [23.7–50.1] 0.286
Indication 0.568
   Male factor 261 (70%)





Table 1. HDL anti-oxidative capacity and cycle characteristics of patients undergoing modified natural cycle 
IVF. P values are derived from generalized estimating equations and describe the effect of cycle characteristics 
on HDL anti-oxidative capacity. Data are expressed as mean ± standard deviation, median [interquartile range] 
or number of cases (percentage) of outcome. The relationship between cycle characteristics of patients and 
reduction in oxidation was estimated by univariate GEE. aBMI at start of the fertility treatment episode. Values 
are missing for 31 cycles corresponding to 22 patients. bDuration of subfertility at intake. Data are missing for 14 
cycles corresponding to 11 patients.
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undergo cell cleavage and were therefore discarded. Finally, in 244 monofollicular MNC cycles the embryo was 
suitable for transfer, which resulted in 67 positive pregnancy tests from 64 patients.
A higher FF-HDL anti-oxidative capacity was associated with decreased odds of the oocyte undergoing nor-
mal fertilization (Table 3), an association that remained significant after adjustment for age, BMI and smoking 
(OR 0.97 [0.93–1.00], p = 0.041). No significant relationship with the corresponding oocyte (progression to met-
aphase II in ICSI), embryo (fragmentation, top quality embryo) and pregnancy parameters (positive pregnancy 
test) was found.
Discussion
The results of this study demonstrate that (i) FF has anti-oxidative capacity of which the majority is attributable 
to the presence of HDL, and (ii) an increase in FF anti-oxidative function was associated with a decreased chance 
for the oocyte to undergo normal fertilization. The above findings suggest that beyond being a cholesterol carrier, 
FF-HDL have an anti-oxidative function that is related to the developmental potential of the oocyte during the 
initial phases of zygote development.
HDL are small lipoprotein particles of complex composition which are, according to our results, responsible 
for more than 80% of the total FF anti-oxidative function. Moreover, the significantly increased anti-oxidative 
properties of FF as compared to apolipoprotein B-depleted plasma indicate the existence of an environment 
relatively enriched in anti-oxidant capacity surrounding the developing oocyte. This finding is in accordance 
with previous work showing that FF from women undergoing (albeit hyperstimulation) IVF contains signifi-
cantly lower levels of oxidative stress markers (conjugated dienes, lipid hydroperoxides and thiobarbituric acid 
reactive substances) and has a higher total antioxidant capacity as compared to plasma20,21. Extending current 
knowledge, the present study shows that the net pro-oxidative property of FF is mainly due to local HDL particles. 
Figure 2. Comparison of the abundance of HDL-associated proteins between HDL from follicular fluid and 
from matched plasma (n = 6 each). Protein intensity ratio was calculated as the median protein intensity 
in follicular fluid-HDL samples divided by the median protein intensity in matched plasma-HDL samples. 
Apolipoprotein D and serum amyloid A1 could not be detected in plasma-HDL from one patient and in 
follicular fluid-HDL and plasma-HDL from three patients, respectively, hence the n number for these proteins 
is lower. *P < 0.05 by Wilcoxon Signed Ranks test (protein intensity). Apo – apolipoprotein, SAA – serum 
amyloid A, PON1 – paraoxonase/arylesterase 1.
Number of cycles Anti-ox (%)
Progression to metaphase 
II (ICSI)
Yes (n = 287)
No (n = 15)
81.7 ± 7.2
83.5 ± 6.3




Low (less than 10%) 
(n = 199)
High (more than 
10%) (n = 45)
81.6 ± 6.7
80.0 ± 6.9
Top quality embryo Yes (n = 128)No (n = 208)
81.5 ± 6.9
81.9 ± 6.7
Pregnancy Yes (n = 67)No (n = 177)
81.4 ± 7.4
81.3 ± 6.5
Table 2. Oocyte and embryo development in Modified Natural Cycle IVF and ICSI and follicular fluid anti-
oxidative capacity. Data are expressed as mean ± standard deviation or median [interquartile range]. Anti-ox, 
anti-oxidative function.
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Moreover, the anti-oxidative function of FF-HDL fluctuates within a narrow range with a relatively stable and low 
intra-individual variation between cycles.
Despite the expected diffusion of HDL from blood across the blood-follicle barrier, FF and plasma-derived 
HDL differ in size and composition, indicating that during transport, remodelling of HDL occurs6. In support 
of such a concept, we detected significant differences in the HDL proteome between the two matrices, namely a 
decreased apolipoprotein E, apolipoprotein C-II and apolipoprotein C-III content of FF-HDL. However, more 
obvious candidates for HDL-associated proteins with an anti-oxidative function such as PON1, apolipoprotein 
A-I, apolipoprotein A-IV or the S1P carrier apolipoprotein M were not differentially present on FF compared with 
plasma HDL. In contrast, FF-HDL was enriched in vitamin E and S1P, which may conceivably contribute to the 
accentuated anti-oxidative potential of FF as compared to plasma HDL. Previous literature reported lower levels 
of apolipoprotein A-I and apolipoprotein A-IV in apolipoprotein B-precipitated FF-HDL than in matched serum 
or plasma6,22. This discrepancy is likely due to different stimulation protocols; specifically, the higher amounts of 
hormones used in hyperstimulation-IVF in previous literature may influence oxidative balance in the follicular 
environment.
The present study found a negative correlation between the FF-HDL anti-oxidative capacity and the chance 
of the oocyte undergoing normal fertilization, which may seem counterintuitive. However, the optimum balance 
of pro- and anti-oxidants for successful fertilization has yet to be established, and previous literature implies that 
both extremes of the oxidative stress spectrum may be detrimental for oocyte maturation and embryo quality. 
Specifically, our finding is in agreement with the study of Sabatini et al. who reported an inverse correlation 
between FF levels of the antioxidant superoxide dismutase and fertilization rates23. Moreover, anti-oxidative 
defence may increase in response to high stress, such as seen for example in smokers24. Increased anti-oxidant 
function may thus reflect the need of the oocyte for increased protection in unfavourable developmental condi-
tions and is likely part of a functioning defence mechanism against oxidative stress. Further, a certain amount 
of oxidative stress may be necessary for normal reproductive physiology, as is suggested by a previous study in 
which all pregnancies occurred in women with mid-range FF oxidative-stress indices25. In addition, oxygen rad-
icals represent an ancient signalling system important for many biological processes, among others for providing 
guidance cues during development26. On the other hand, Oyawoye et al. found that an increase in the total antiox-
idant capacity of FF was associated with successful oocyte fertilization, which may reflect the detrimental effects 
of excess oxidative stress27. Efforts have also been made to determine the upper limit of ROS beyond which it 
becomes toxic for the oocyte28. However, it is rather difficult to draw an exact conclusion about the physiological 
limits for the pro-/anti-oxidant balance due to different laboratory pro-/anti-oxidant measurement techniques 
and hormonal stimulation protocols used in fertility research.
The present study did not find a relationship between the FF-HDL anti-oxidative function and the occur-
rence of pregnancy, which is in agreement with previous work20. This finding may be attributable to the fact that, 
aside from the pre-ovulatory environment of oocyte development, extra-ovarian factors such as endometrial 
receptivity and sperm quality are crucial determinants of pregnancy. Nonetheless, previous studies have reached 
conflicting conclusions about a possible detrimental versus beneficial role of FF oxidative stress on the chances of 
achieving a successful pregnancy21,29–32. The difference in study outcomes may be explained by differences in IVF 
procedures and patient characteristics. In MNC-IVF, the patient’s natural ovulatory cycles are followed, hence a 
much lower dose of gonadotropins is administered which is likely to influence the FF total antioxidant capacity33. 
The lower doses of exogenous hormones result in the development of only one dominant follicle. Consequently, 
only one oocyte is fertilized and single embryo transfer is performed. MNC-IVF is thus much closer to normal 
physiology of ovarian follicle growth as compared to the conventional hyperstimulation protocols.
We therefore consider one of the strengths of our study the use of material from MNC-IVF, which allows for 
correlating components of FF with oocyte, embryo and pregnancy outcomes. Additionally, the current study 
highlights one of the previously unrecognized key players in the FF oxidative balance, namely HDL, and quan-
tified its contribution to the total local functional antioxidant capacity. The present study also has certain lim-
itations. Firstly, this is a single centre study. Secondly, dynamic HDL function assays are not standardized as 
e.g. clinical chemistry determinations of static biomarkers, and results have to be interpreted in the context of 
the respective conditions applied10. Lastly, due to the invasive nature of the oocyte pick-up procedure, minor 
Unadjusted model Adjusted model
Odds ratio (95% CI) p value Odds ratio (95% CI) p value
Progression to metaphase 
II (ICSI) 0.97 (0.91–1.02) 0.220 0.97 (0.91–1.02) 0.225
Normal fertilization 0.97 (0.94–1.00) 0.042 0.97 (0.93–1.00) 0.041
Low fragmentationa 1.03 (0.98–1.08) 0.208 1.04 (1.00–1.09) 0.068
Top quality embryo 1.00 (0.97–1.03) 0.898 1.00 (0.97–1.04) 0.805
Pregnancy 1.00 (0.96–1.05) 0.906 1.01 (0.96–1.06) 0.703
Table 3. Generalized estimating equations analysis of the relationship between embryo development in 
Modified Natural Cycle IVF and ICSI and follicular fluid anti-oxidative capacity. Adjusted model includes 
percentage reduction in LDL oxidation, maternal age, BMI, smoking. Additionally, models for normal 
fertilization and pregnancy include the type of fertility treatment (IVF or ICSI) and duration of subfertility, 
respectively. Bold values: p < 0.05 in GEE analysis. aAfter exclusion of one extreme outlier (FF-HDL anti-
oxidative function of 55.58%): adjusted OR 1.03 (0.98–1.08), p value = 0.202.
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contamination of the FF samples with blood cannot be completely excluded. However, since the anti-oxidative 
capacity of FF-HDL is higher, that would rather be expected to result in a dilution of the observed effect size.
Investigating HDL function is an emerging concept in cardiovascular medicine, and several studies have 
found an increased prevalence of cardiovascular disease risk in women with ovulatory failure due to e.g. poly-
cystic ovarian disease, endometriosis or primary ovarian insufficiency16–18. Given the perceived ability of HDL 
to diffuse across the ovarian blood-follicle barrier, lifestyle and drug interventions to modify the functionality of 
HDL may also affect reproductive outcomes by e.g. interfering with known risk factors for infertility such as the 
components of the metabolic syndrome in which HDL dysfunction may be expected34–38.
In summary, this study shows that FF is a matrix with accentuated anti-oxidative properties that are pre-
dominantly exerted by HDL in the pre-ovulatory follicular environment. Moreover, differences in anti-oxidative 
capacity between FF- and plasma-HDL might be explained by an altered lipid composition of the particles. 
Importantly, an increase in the anti-oxidative function of FF-HDL seems to be a negative predictor of normal 
fertilization, which may be the reflection of an unfavourable ovarian environment that stimulated anti-oxidant 
activity. Further studies are warranted to gain more insight into the relationship between FF-HDL function and 
embryo quality as well as pregnancy chances in IVF. Moreover, fine-tuning the balance between oxidative stress 
and antioxidants is conceivably required in order to exploit this system for therapeutic purposes, with the ulti-
mate goal of optimizing reproductive success in IVF procedures.
Methods
Sample and data collection. Surplus FF and blood from ovulatory women attending the fertility clinic of 
the University Medical Centre Groningen in the years 2013–2017 for a maximum of six cycles of MNC-IVF was 
used for the current study. Patients attending the IVF clinic between August 2013 and July 2014 were included 
in an observational setting as part of routine medical care. From October 2014 to April 2017 IVF patients were 
enrolled in a prospective observational cohort study on the relationship between women’s nutrition, blood bio-
markers, FF composition and MNC-IVF outcome parameters. There were no differences in hormonal treatment, 
ovum pick-up or laboratory procedures between the two sequentially recruited patient groups.
On the day of oocyte retrieval, a fasted blood sample was drawn and the surplus plasma was stored at −80 °C. 
After the oocyte had been collected for IVF/ICSI, the FF was centrifuged for 20 minutes at 300 g and the super-
natant was stored at −80 °C for later analysis. FF supernatant with visible or suspected blood contamination was 
discarded. Materials from each cycle were assigned non-traceable codes and information regarding the partici-
pants and IVF outcomes were gathered from a database for routine patient care. MNC-IVF has the advantage of 
being as close to normal reproductive physiology as possible.
For the present study, samples were used from cycles in which (i) one dominant follicle developed, (ii) one 
oocyte was retrieved and (iii) macroscopic blood contamination of FF was minimal.
Ethical approval. For the present study, plasma and FF were used, which are considered waste materials 
that would otherwise be discarded. For the prospective study (Netherlands Trial Register number NTR4409), 
patients were asked to fill in food frequency questionnaires; for this additional task, medical ethics committee 
approval was obtained (Medisch Ethische Toetsingscommissie 2014/007, number NL47569.042.13) and all par-
ticipants gave written informed consent before inclusion in the study. For the usage of samples collected during 
routine medical care, approval was requested at the Medical Ethical Committee of the UMCG but waived, since 
all patients had signed a universal consent form that permits the usage of surplus material and data from medical 
records for research purposes under the condition that the patient identity remains untraceable and the data 
confidential. The research was conducted in accordance with the Declaration of Helsinki.
Fertility treatment. The MNC-IVF procedure was carried out as previously described (Supplementary 
methods)5. The oocyte underwent standard insemination in the form of incubation with medium containing 
spermatozoa or intracytoplasmatic sperm injection (ICSI) within 6 h of retrieval. The number of pronuclei was 
assessed on the morning of day 1 after insemination/spermatozoa injection and cleavage, the number of blas-
tomeres, percentage of fragmentation and presence or absence of multinucleated blastomeres (MNBs) on day 
2 after insemination. Normal fertilization was defined as the presence of either zero, one or two pronuclei on 
day 1 and the occurrence of cell cleavage on day two. Abnormal fertilization was defined as the presence of three 
pronuclei on day 1 or the absence of cell cleavage on day two, irrespective of the number of pronuclei on day 1. 
Top quality embryos were defined as the presence of two pronuclei on day 1 and presence of four cells, absence 
of MNBs and less than 20% fragmentation on day two after fertilization. Single embryo transfer took place on 
day two after oocyte retrieval. Embryos containing more than two pronuclei or more than 40% fragmentation 
were discarded. On days 5, 8 and 11 after oocyte retrieval, hCG (1500 IU, Pregnyl, MSD) was administered for 
luteal support. The occurrence of pregnancy was defined by a positive serum hCG test at two weeks after embryo 
transfer. Ongoing pregnancy (defined as the presence of an intrauterine gestational sac with fetal heartbeat) was 
confirmed by ultrasound at 12 weeks gestational age.
HDL anti-oxidative function. HDL was isolated from plasma by precipitating apoB-containing lipopro-
teins using polyethylene glycol-6000 (Sigma-Aldrich, Germany) exactly as detailed previously39. For FF samples, 
apoB-containing lipoproteins were not precipitated, since FF is already almost entirely devoid of these6.
The anti-oxidative capacity of FF and plasma HDL was studied by adding individual FF and apoB-depleted 
plasma samples to native, unoxidized LDL particles as previously published39–43. Oxidation was induced by 
2,2’-azobis [2-amidinopropane] dihydrochloride (2.5 mM; AAPH, Sigma, Germany) in aliquots of native LDL 
(3.6 mM cholesterol concentration), to which either PBS (2.5 µl; control) or FF (2.5 µl) or apoB-depleted plasma 
(2.5 µl) was added. Anti-oxidative function was calculated as the capacity of HDL to suppress the maximally 
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induced LDL oxidation. Consequently, higher values describe lower oxidation, and thus better protection. The 
inter-assay coefficient of variation of the assay was previously determined to be 5.1%19,40,42,43.
To assess the contribution of FF-HDL to the total FF anti-oxidative capacity, HDL was isolated from eight first 
cycle MNC FF samples from individual patients by fast protein liquid chromatography (FPLC)44. Cholesterol 
content in individual fractions after FPLC was measured using a routine enzymatic colorimetric method (Roche 
Diagnostics GmbH, The Netherlands). For each sample, the FPLC fractions corresponding to HDL (as deter-
mined by fraction number and cholesterol content) were pooled and anti-oxidant capacity was subsequently 
determined as described above in the concentrated HDL and in the whole FF sample (in total 16 samples corre-
sponding to the above-mentioned eight patients).
HDL composition. Differential protein composition of plasma- versus FF-HDL particles isolated by FPLC 
was assessed by untargeted proteomics as follows. First, for in solution digestion 10 µL of 0.2% Rapigest in milliQ 
water was added to the protein mixtures (50 µg) followed by 10 µL of 100 mM Ammonium BiCarbonate (ABC) 
in milliQ water. The sample was reduced by adding 10 µL of 10 mM DTT in 100 mM ABC buffer and incubated 
at 56 °C for 30 minutes. The sample was cooled down to room temperature (RT) and alkylated by adding 10 µL 
of a 55 mM Iodoacetamide in 100 mM ABC buffer and left at RT in the dark for 45 minutes. Alkylation was 
quenched by addition of 10 µL 10 mM DTT in 100 mM ABC buffer. 25 µL of a 10 ng/µl trypsin in 100 mM ABC 
buffer was added and the sample was incubated in an oven at 37 °C. After two hours an additional 25 µL of a 
10 ng/µl trypsin in 100 mM ABC buffer was added and incubated overnight at 37 °C. Samples were acidified by 
addition of 10 µL 10% (v/v) TFA in water and incubated at 37 °C. After 45 minutes the samples were spun down 
and the supernatant was concentrated and desalted by Stage Tip cleanup and finally eluted in 20 µL 50% acetoni-
trile/0.1%TFA. The samples were dried in a speedvac and resuspended in 20 µl 5% formic acid for analysis by 
LCMS. LC-MS/MS of the tryptic peptides was performed with the Ultimate 3000 HPLC system coupled online 
to a Q-Exactive-Plus mass spectrometer with a NanoFlex source (both from Thermo Fisher Scientific) equipped 
with a stainless-steel emitter. 1 µL of tryptic digest was loaded onto a 5 mm × 300 µm i.d. trapping micro column 
packed with PepMAP100 5 µm particles (Dionex) in 0.1% FA at the flow rate of 20 µL/min. After loading and 
washing for 3 minutes, peptides were back-flush eluted onto a 50 cm × 75 µm i.d. nano-column, packed with 
Acclaim C18 PepMAP100 2 µm particles (Dionex). The following mobile phase gradient was delivered at the 
flow rate of 300 nL/min: 2–45% of solvent B in 90 min; 50–80% B in 1 min; 80% B during 14 min, and back to 3% 
B in 1 min and held at 2% B for 24 minutes. Solvent A was 100:0 H2O/acetonitrile (v/v) with 0.1% formic acid 
and solvent B was 0:100 H2O/acetonitrile (v/v) with 0.1% formic acid. The mass spectrometer was operated in 
data-dependent mode to switch automatically between MS and MS/MS and the top 15 precursor ions with a 
charge state of 2–5+ were selected with an isolation width of 1.8 m/z and fragmented by HCD (resolution 17500, 
max IT = 50 ms) with a 20 seconds exclusion time. The normalized collision energy was set at 28. For database 
search and label free quantitation (LFQ) the software PEAKS X (Bioinformatics Solutions Inc., Waterloo, Ontario, 
Canada) was applied to the spectra generated by the Q-exactive plus mass spectrometer to search against the 
Human SwissProt database (2019.04.02/20404 entries) with fixed modification carbamidomethylation of cysteine 
and the variable post translational modifications oxidation of methionine (done with a maximum of 5 posttrans-
lational modifications per peptide at a parent mass error tolerance of 20 ppm and a fragment mass tolerance of 
0.04 Da). False discovery rate was set at 1 and at least 1 unique peptide should be present. LFQ was performed 
using the PeaksQ module incorporated in the Peaks X software.
Vitamin E and sphingosine-1-phosphate (S1P) were measured in HDL isolated from FF and plasma by FPLC 
using commercially available ELISA kits (MBS163944 and MBS163661, MyBioSource, San Diego, USA) following 
the instructions provided by the manufacturer. Final volume after pooling of FPLC HDL fractions and concentra-
tion of the sample was used to normalize the results.
Statistical analysis. Results are expressed as mean ± standard deviation for normally distributed vari-
ables and median [interquartile range] for non-normally distributed variables. Extreme outliers were defined 
as cases with values more than three times the interquartile range above the third quartile or below the first 
quartile. Statistical analysis after exclusion of extreme outliers was compared with original results. Differences 
in HDL anti-oxidative capacity between FF and matched plasma, between the maximum and minimum HDL 
anti-oxidative function and between lipid and protein content of FF-HDL and plasma-HDL were analysed by 
means of Wilcoxon Signed Ranks test (paired), and their correlation was expressed as Spearman’s r. To study the 
relationship between FF anti-oxidative function and oocyte, embryo and pregnancy parameters, as well as the 
relationship between FF anti-oxidative function and cycle characteristics, multilevel analysis using generalized 
estimating equations (GEE) was used45. The results of GEE analysis are presented as odds ratio (95% confidence 
interval). A p value lower than 0.05 was considered statistically significant. Factors known from literature to influ-
ence fertility (age, BMI, smoking, type of procedure – IVF or ICSI – specifically for fertilization) and factors that 
were significantly correlated to MNC-IVF outcomes were included in the adjusted GEE model. SPSS 23 (SPSS, 
Inc., Chicago, IL, USA) was used for data analysis.
Data Availability
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
References
 1. Hovingh, G. K., Rader, D. J. & Hegele, R. A. HDL re-examined. Curr. Opin. Lipidol. 26, 127–132 (2015).
 2. Fujimoto, V. Y., Kane, J. P., Ishida, B. Y., Bloom, M. S. & Browne, R. W. High-density lipoprotein metabolism and the human embryo. 
Hum. Reprod. Update 16, 20–38 (2010).
 3. Gautier, T. et al. Human luteinized granulosa cells secrete apoB100-containing lipoproteins. J. Lipid Res. 51, 2245–2252 (2010).
8Scientific RepoRtS |         (2019) 9:12817  | https://doi.org/10.1038/s41598-019-49091-3
www.nature.com/scientificreportswww.nature.com/scientificreports/
 4. Wallace, M. et al. An investigation into the relationship between the metabolic profile of follicular fluid, oocyte developmental 
potential, and implantation outcome. Fertil. Steril. 97(1078–84), e1–8 (2012).
 5. Nagy, R. A. et al. Presence of bile acids in human follicular fluid and their relation with embryo development in modified natural 
cycle IVF. Hum. Reprod. 30, 1102–1109 (2015).
 6. Jaspard, B. et al. Structural and functional comparison of HDL from homologous human plasma and follicular fluid. A model for 
extravascular fluid. Arterioscler. Thromb. Vasc. Biol. 17, 1605–1613 (1997).
 7. Stouffer, R. L., Xu, F. & Duffy, D. M. Molecular control of ovulation and luteinization in the primate follicle. Front. Biosci. 12, 
297–307 (2007).
 8. Yesilaltay, A. et al. Excess cholesterol induces mouse egg activation and may cause female infertility. Proc. Natl. Acad. Sci. USA 111, 
E4972–80 (2014).
 9. Miettinen, H. E., Rayburn, H. & Krieger, M. Abnormal lipoprotein metabolism and reversible female infertility in HDL receptor 
(SR-BI)-deficient mice. J. Clin. Invest. 108, 1717–1722 (2001).
 10. Triolo, M., Annema, W., Dullaart, R. P. & Tietge, U. J. Assessing the functional properties of high-density lipoproteins: an emerging 
concept in cardiovascular research. Biomark Med. 7, 457–472 (2013).
 11. Zhao, H. et al. Metabolism alteration in follicular niche: The nexus among intermediary metabolism, mitochondrial function, and 
classic polycystic ovary syndrome. Free Radic. Biol. Med. 86, 295–307 (2015).
 12. Liu, F., He, L., Liu, Y., Shi, Y. & Du, H. The expression and role of oxidative stress markers in the serum and follicular fluid of patients 
with endometriosis. Clin. Exp. Obstet. Gynecol. 40, 372–376 (2013).
 13. Singh, A. K., Chattopadhyay, R., Chakravarty, B. & Chaudhury, K. Markers of oxidative stress in follicular fluid of women with 
endometriosis and tubal infertility undergoing IVF. Reprod. Toxicol. 42, 116–124 (2013).
 14. Artimani, T. et al. Evaluation of pro-oxidant-antioxidant balance (PAB) and its association with inflammatory cytokines in 
polycystic ovary syndrome (PCOS). Gynecol. Endocrinol. 34, 148–152 (2018).
 15. Kontush, A. & Chapman, M. J. Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of 
dyslipidemia, inflammation, and atherosclerosis. Pharmacol. Rev. 58, 342–374 (2006).
 16. Kvaskoff, M. et al. Endometriosis: a high-risk population for major chronic diseases? Hum. Reprod. Update 21, 500–516 (2015).
 17. Wild, R. A. Dyslipidemia in PCOS. Steroids 77, 295–299 (2012).
 18. Daan, N. M. et al. Cardiovascular Risk in Women With Premature Ovarian Insufficiency Compared to Premenopausal Women at 
Middle Age. J. Clin. Endocrinol. Metab. 101, 3306–3315 (2016).
 19. Kappelle, P. J. et al. Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL. Eur. J. Clin. Invest. 
42, 487–495 (2012).
 20. Jozwik, M., Wolczynski, S., Jozwik, M. & Szamatowicz, M. Oxidative stress markers in preovulatory follicular fluid in humans. Mol. 
Hum. Reprod. 5, 409–413 (1999).
 21. Pasqualotto, E. B. et al. Effect of oxidative stress in follicular fluid on the outcome of assisted reproductive procedures. Fertil. Steril. 
81, 973–976 (2004).
 22. Browne, R. W. et al. Distributions of high-density lipoprotein particle components in human follicular fluid and sera and their 
associations with embryo morphology parameters during IVF. Hum. Reprod. 23, 1884–1894 (2008).
 23. Sabatini, L., Wilson, C., Lower, A., Al-Shawaf, T. & Grudzinskas, J. G. Superoxide dismutase activity in human follicular fluid after 
controlled ovarian hyperstimulation in women undergoing in vitro fertilization. Fertil. Steril. 72, 1027–1034 (1999).
 24. Charalabopoulos, K. et al. Effects of cigarette smoking on the antioxidant defence in young healthy male volunteers. Int. J. Clin. 
Pract. 59, 25–30 (2005).
 25. Wiener-Megnazi, Z. et al. Oxidative stress indices in follicular fluid as measured by the thermochemiluminescence assay correlate 
with outcome parameters in in vitro fertilization. Fertil. Steril. 82(Suppl 3), 1171–1176 (2004).
 26. Valko, M. et al. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 
44–84 (2007).
 27. Oyawoye, O. et al. Antioxidants and reactive oxygen species in follicular fluid of women undergoing IVF: relationship to outcome. 
Hum. Reprod. 18, 2270–2274 (2003).
 28. Jana, S. K., K, N. B., Chattopadhyay, R., Chakravarty, B. & Chaudhury, K. Upper control limit of reactive oxygen species in follicular 
fluid beyond which viable embryo formation is not favorable. Reprod. Toxicol. 29, 447–451 (2010).
 29. Attaran, M. et al. The effect of follicular fluid reactive oxygen species on the outcome of in vitro fertilization. Int. J. Fertil. Womens 
Med. 45, 314–320 (2000).
 30. Oral, O. et al. The effects of oxidative stress on outcomes of assisted reproductive techniques. J. Assist. Reprod. Genet. 23, 81–85 
(2006).
 31. Matzuk, M. M., Dionne, L., Guo, Q., Kumar, T. R. & Lebovitz, R. M. Ovarian function in superoxide dismutase 1 and 2 knockout 
mice. Endocrinology 139, 4008–4011 (1998).
 32. Ho, Y. S. et al. Reduced fertility in female mice lacking copper-zinc superoxide dismutase. J. Biol. Chem. 273, 7765–7769 (1998).
 33. Aydogan, M. B. et al. Comparison of antagonist mild and long agonist protocols in terms of follicular fluid total antioxidant capacity. 
Taiwan. J. Obstet. Gynecol. 57, 194–199 (2018).
 34. Nobecourt, E. et al. Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated 
oxidative stress and hyperglycaemia. Diabetologia 48, 529–538 (2005).
 35. Hansel, B. et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein 
particles displaying impaired antioxidative activity. J. Clin. Endocrinol. Metab. 89, 4963–4971 (2004).
 36. Annema, W. et al. Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM 
study. Sci. Rep. 6, 27367 (2016).
 37. Hansel, B. et al. Lifestyle intervention enhances high-density lipoprotein function among patients with metabolic syndrome only at 
normal low-density lipoprotein cholesterol plasma levels. J. Clin. Lipidol. 10, 1172–1181 (2016).
 38. Casella-Filho, A. et al. Effect of exercise training on plasma levels and functional properties of high-density lipoprotein cholesterol 
in the metabolic syndrome. Am. J. Cardiol. 107, 1168–1172 (2011).
 39. Leberkuhne, L. J. et al. The predictive value of the antioxidative function of HDL for cardiovascular disease and graft failure in renal 
transplant recipients. Atherosclerosis 249, 181–185 (2016).
 40. Bakker, L. E. et al. HDL functionality in South Asians as compared to white Caucasians. Nutr. Metab. Cardiovasc. Dis. 26, 697–705 
(2016).
 41. Dullaart, R. P., de Boer, J. F., Annema, W. & Tietge, U. J. The inverse relation of HDL anti-oxidative functionality with serum amyloid 
a is lost in metabolic syndrome subjects. Obesity (Silver Spring) 21, 361–366 (2013).
 42. Annema, W. et al. HDL function is impaired in acute myocardial infarction independent of plasma HDL cholesterol levels. J. Clin. 
Lipidol. 10, 1318–1328 (2016).
 43. Dullaart, R. P., Annema, W., de Boer, J. F. & Tietge, U. J. Pancreatic beta-cell function relates positively to HDL functionality in well-
controlled type 2 diabetes mellitus. Atherosclerosis 222, 567–573 (2012).
 44. Nijstad, N. et al. Scavenger receptor BI-mediated selective uptake is required for the remodeling of high density lipoprotein by 
endothelial lipase. J. Biol. Chem. 284, 6093–6100 (2009).
 45. Zeger, S. L. & Liang, K. Y. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42, 121–130 (1986).
9Scientific RepoRtS |         (2019) 9:12817  | https://doi.org/10.1038/s41598-019-49091-3
www.nature.com/scientificreportswww.nature.com/scientificreports/
Acknowledgements
We are indebted to the staff of the Reproductive Medicine laboratory of the University Medical Centre Groningen 
for collection of patient materials and technical expertise in assisted reproductive medicine. We are grateful to 
Marcel de Vries from the Mass Spectrometry Centrum of the University of Groningen for technical assistance and 
expertise in untargeted proteomics.
Author Contributions
R.A.N. contributed to study design, execution, analysis, manuscript drafting and critical discussion. A.P.A.v.M. 
contributed to study design, analysis and critical discussion. H.G. contributed to analysis and critical discussion. 
I.H. contributed to study design, execution and critical discussion. D.A., R.H.M. and J.L.C.A. contributed to 
execution and critical discussion. A.H. and U.J.F.T. contributed to study design, execution, analysis, manuscript 
drafting and critical discussion. All authors reviewed the manuscript.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-019-49091-3.
Competing Interests: A.H. declares that the Department of Obstetrics and Gynaecology of the University 
Medical Groningen received an unrestricted educational grant of Ferring Pharmaceutical BV, the Netherlands. 
R.A.N., A.P.A.vM., H.G., I.H., D.A., R.H.M., J.L.C.A. and U.J.F.T. declare no potential conflict of interest.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2019
